Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap32.80B
Enterprise Value31.87B
Trailing P/E21.95
Forward P/E18.45
RMD
(NYSE)ResMed Inc.
$224.09-- (--)
Loading... - Market loading
ResMed (RMD) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)6.04
Forward Price/Sales5.52
Price/Book (mrq)5.16
Price/Tangible Book (mrq)11.46
Price/FCF (ttm)18.36
Price/OCF (ttm)17.04
PEG Ratio1.16
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue5.90
EV/Earnings21.45
EV/EBITDA15.25
EV/EBIT17.29
EV/FCF17.94
Stock Price
Current price, 52-week range, and moving averages
Current Price$224.09
1-Day Change-0.73%
52-Week High$293.81
52-Week Low$199.92
52-Week Change0.25%
YTD Change-8.97%
1-Year Change-0.07%
50-Day MA$247.80
200-Day MA$259.09
Avg Volume (30 day)626.86K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding146.37M
Book Value per Share$43.18
Net Cash per Share$7.91
FCF per Share$12.14
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$294.67
Target Upside/Downside31.50%
Analyst ConsensusBuy
Analyst Count11
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin60.87%
EBITDA Margin (ttm)38.70%
EBIT Margin (ttm)34.14%
Operating Margin (ttm)34.14%
Pretax Margin (ttm)33.69%
Profit Margin (ttm)27.53%
FCF Margin (ttm)32.91%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)23.51%
Return on Assets (ttm)17.47%
Return on Invested Capital (ttm)27.04%
Return on Capital Employed (ttm)25.40%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue5.40B
Gross Profit3.29B
Operating Income1.84B
Pretax Income1.82B
Net Income1.49B
EBITDA2.09B
EBIT1.84B
Diluted EPS$10.15
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow1.91B
Capital Expenditures137.90M
Free Cash Flow1.78B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth15.21%
Dividend Growth12.56%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)8.50B
Cash & Securities (mrq)1.42B
Net Cash (mrq)1.16B
Net Cash per Share$7.91
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)663.83M
Working Capital (mrq)2.57B
Total Equity (mrq)6.32B
Book Value per Share$43.18
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)3.06
Quick Ratio (mrq)2.32
Debt/Equity (mrq)0.11
Debt/EBITDA (ttm)0.32
Debt/FCF (ttm)0.37
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$2.33
Dividend Yield1.05%
Payout Ratio (Earnings)22.95%
Payout Ratio (FCF)19.20%
Dividend Growth (YoY)12.56%
Ex-Dividend DateFeb 12, 2026
Pay DateMar 19, 2026
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield4.56%
FCF Yield5.45%
Buyback Yield0.54%
Total Shareholder Yield1.59%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score11.77
Piotroski F-Score7/9
Dividend Score56.53
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Lynch Fair Value$192.09
Lynch Upside/Downside-13.80%
Graham Number$99.31
Graham Upside/Downside-55.43%
Frequently Asked Questions About ResMed Statistics
What are the key financial metrics for RMD?
ResMed Inc. (RMD) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is RMD's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether ResMed is overvalued or undervalued.
How do I read RMD's profitability ratios?
ResMed's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do RMD's debt ratios indicate?
The financial health section shows ResMed's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is RMD's dividend analysis?
The dividend section covers ResMed's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.